PT  - JOURNAL ARTICLE
AU  - Guy Tennenholtz
AU  - Constantine Caramanis
AU  - Shie Mannor
TI  - Sequential Vaccination for Containing Epidemics
AID  - 10.1101/2020.04.13.20060269
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.13.20060269
4099  - http://medrxiv.org/content/early/2020/04/14/2020.04.13.20060269.short
4100  - http://medrxiv.org/content/early/2020/04/14/2020.04.13.20060269.full
AB  - The dynamics of infectious diseases spread is crucial in determining their risk and offering ways to contain them. We study sequential vaccination of individuals in networks, where there is a limit on the number of individuals that can be vaccinated every day. Effective allocation of vaccine will play a critical role in preventing the spread and reducing the effects of a future pandemic. We derive methods for calculating upper and lower bounds of the expected number of infected individuals, as well as provide estimates on the number of vaccinations that is needed for containment. We calculate these explicitly on trees, d-dimensional grids, and Erdős Rényi graphs. Finally, we construct a time-dependent budget allocation strategy and demonstrate its superiority over constant budget allocation on real networks following first acquaintance vaccination. Our results provide a principled approach to assess the needed vaccination rate given the social graph topology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementISF Contract 1380/16.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used is open source